Sofina Ventures has sold a 1.28% stake in Honasa Consumer for Rs 177 crore.
Belgium-based investment firm Sofina Ventures SA has reduced its holding in Honasa Consumer, the parent company of beauty and personal care brand Mamaearth, by selling shares worth approximately Rs 177 crore through a bulk deal on the National Stock Exchange (NSE).
The transaction comes as Honasa Consumer continues to broaden its presence beyond skincare and beauty through strategic acquisitions in nutraceuticals and men’s personal care. While Sofina’s latest sale reflects a gradual reduction in its shareholding, the company itself continues to pursue expansion opportunities across high-growth consumer wellness categories.
Sofina Cuts Its Stake in Honasa Consumer
According to NSE bulk deal data, Sofina Ventures sold 4.18 million shares of Honasa Consumer on 25 June at an average price of Rs 424.07 per share.
The transaction was valued at approximately Rs 177.2 crore.
At the end of the March 2026 quarter, Sofina owned 3.29% of Honasa Consumer. Following the latest transaction, its holding is estimated to have declined to around 2.0%, assuming no other changes in share ownership.
The share sale represents another instance of an early-stage institutional investor partially monetising its investment after the company became publicly listed.
Market Reaction Remained Stable
Despite the bulk sale, investor sentiment remained largely unaffected.
Honasa Consumer shares closed 0.42% higher at Rs 417.70 on the NSE on Thursday, suggesting that the transaction had already been absorbed by the market without creating significant selling pressure.
Large institutional stake sales are common after IPOs, particularly when early investors gradually rebalance their portfolios while maintaining exposure to long-term growth prospects.
Honasa Continues Expanding Beyond Beauty
The stake sale comes during an active phase of expansion for Honasa Consumer.
Earlier this week, the company announced approval for the acquisition of a 58% stake in Fluence Pharma, marking its formal entry into India’s rapidly growing nutraceuticals market.
The acquisition remains subject to customary closing adjustments and regulatory conditions.
The move follows another strategic acquisition completed recently, where Honasa acquired a 95% stake in BTM Ventures, the parent company of Reginald Men, a men’s personal care brand.
Together, these acquisitions indicate Honasa’s strategy of evolving into a broader consumer wellness company rather than remaining focused solely on skincare and cosmetics.
A Multi-Brand Consumer Platform
Founded by Varun Alagh and Ghazal Alagh, Honasa Consumer has grown into one of India’s leading digital-first consumer goods companies.
Its portfolio now includes several well-known brands across beauty, skincare, and personal care, including:
- Mamaearth
- The Derma Co.
- Aqualogica
- Dr Sheth’s
- BBlunt
- Staze
- Reginald Men
Since its inception, the company has focused on building purpose-driven brands through digital marketing, direct-to-consumer channels, and omnichannel retail expansion.
Financial Performance Shows Continued Growth
For the fourth quarter of FY26, Honasa Consumer reported revenue from operations of Rs 657 crore, compared with Rs 534 crore during the same period last year.
On a like-for-like basis, excluding certain adjustments, revenue stood at approximately Rs 682 crore.
The company also reported a profit after tax (PAT) of around Rs 69 crore during the quarter, reflecting improving profitability alongside revenue growth.
These financial results suggest that Honasa continues to strengthen its operating performance while investing in new growth opportunities.
Why Institutional Investors Reduce Stakes
Sales by early institutional investors such as Sofina are relatively common after companies mature and list on public markets.
Venture capital and private equity firms typically invest during the early growth stages of a business to create long-term value before gradually exiting through IPOs or secondary market transactions.
Such stake reductions do not necessarily indicate declining confidence in a company’s future. Instead, they often reflect portfolio management decisions, capital recycling strategies, or the natural investment lifecycle followed by institutional funds.
In Honasa Consumer’s case, Sofina remains a shareholder even after reducing its ownership.
Looking Ahead
Honasa Consumer is entering a new phase of growth.
Rather than relying exclusively on the success of Mamaearth, the company is steadily building a diversified portfolio spanning skincare, dermatology, men’s grooming, and nutritional wellness.
The acquisitions of Fluence Pharma and Reginald Men demonstrate management’s intent to participate in multiple high-growth consumer categories while leveraging its digital-first brand-building capabilities.
Meanwhile, institutional investors like Sofina continue to unlock value from earlier investments while retaining exposure to the company’s long-term growth potential.
As India’s beauty, wellness, and personal care industry continues expanding, Honasa Consumer’s ability to integrate new businesses, strengthen profitability, and scale multiple brands will remain key factors shaping its next phase of growth.
